| 1 |
35296532 | Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study. | 2022 Mar |
1 |
| 2 |
34715908 | Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol. | 2021 Oct 29 |
4 |
| 3 |
31498074 | Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry. | 2020 Jul-Aug |
1 |
| 4 |
29159893 | Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease. | 2018 Jan |
1 |
| 5 |
29335342 | Comparative Efficacy of Tumor Necrosis Factor-α Inhibitors in Ankylosing Spondylitis: A Systematic Review and Bayesian Network Metaanalysis. | 2018 Apr |
2 |
| 6 |
23942869 | Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol. | 2014 Jan |
1 |
| 7 |
24184736 | Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's disease. | 2014 Mar |
1 |
| 8 |
21642014 | Certolizumab pegol for active Crohn's disease: a placebo-controlled, randomized trial. | 2011 Aug |
2 |
| 9 |
19180261 | Certolizumab pegol in Crohn's disease. | 2008 Nov |
2 |
| 10 |
17516714 | Certolizumab pegol: in Crohn's disease. | 2007 |
1 |
| 11 |
17634458 | Certolizumab pegol for the treatment of Crohn's disease. | 2007 Jul 19 |
1 |
| 12 |
16143120 | A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease. | 2005 Sep |
2 |